Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6382
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Telavancin in Hospital-Acquired and Ventilator-Associated Pneumonia (HAP/VAP) Caused by Staphylococcus aureus: Post Hoc Analysis of 2 Randomized, Controlled Trials ; volume:8 ; number:3 ; day:1 ; month:8 ; year:2019 ; pages:445-452 ; date:9.2019
Infectious diseases and therapy ; 8, Heft 3 (1.8.2019), 445-452, 9.2019
- Urheber
-
Niederman, Michael S.
Lee, Patrick C.
Barriere, Steven L.
Barnes, Chris N.
Castaneda-Ruiz, Bibiana
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-019-0255-0
- URN
-
urn:nbn:de:101:1-2020010207455524100865
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niederman, Michael S.
- Lee, Patrick C.
- Barriere, Steven L.
- Barnes, Chris N.
- Castaneda-Ruiz, Bibiana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study
Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP)
Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update
Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP)
Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
How to remove the grey area between ventilator-associated pneumonia and ventilator-associated tracheobronchitis?
Automated surveillance of non-ventilator-associated hospital-acquired pneumonia (nvHAP): a systematic literature review
Accuracy of ventilator-associated events for the diagnosis of ventilator-associated lower respiratory tract infections
Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia
Ventilator-associated pneumonia in the ICU
Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study
Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP)
Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update
Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP)
Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
How to remove the grey area between ventilator-associated pneumonia and ventilator-associated tracheobronchitis?
Automated surveillance of non-ventilator-associated hospital-acquired pneumonia (nvHAP): a systematic literature review
Accuracy of ventilator-associated events for the diagnosis of ventilator-associated lower respiratory tract infections
Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia
Ventilator-associated pneumonia in the ICU
Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes
Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study
Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP)
Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an Update
Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP)
Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
How to remove the grey area between ventilator-associated pneumonia and ventilator-associated tracheobronchitis?
Automated surveillance of non-ventilator-associated hospital-acquired pneumonia (nvHAP): a systematic literature review
Accuracy of ventilator-associated events for the diagnosis of ventilator-associated lower respiratory tract infections
Impact of appropriate antimicrobial treatment on transition from ventilator-associated tracheobronchitis to ventilator-associated pneumonia